1. Pretreatment Hepatitis C Virus NS5A/NS5B resistance-associated substitutions in genotype 1 uruguayan infected patients;Aldunate;Dis Markers,2018
2. Hepatitis C infections among individuals who received transfusions prior to 1994 in antioquia;Arroyave;Colombia. Rev. Colomb. Gastroenterol.,2014
3. The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection;Bartenschlager;Nat. Rev. Microbiol.,2013
4. Hepatitis C virus seroprevalence in multi-transfused patients in Colombia;Beltrân;J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol.,2005
5. Current therapeutics against HCV;Bhattacharjee;Virusdisease,2021